1xbet 리뷰

News Releases

News releases related to ophthalmology

2023

8 SEP 2023

Pharmaceuti1xbet 리뷰ls

Otsuka collaborates with Shape^TX to develop novel AAV gene t1xbet 리뷰rapies for ocular diseases

2020

16 JUN 2020

Pharmaceuti1xbet 리뷰ls

Launch of a New Combination Ophthalmic Solution for the Treatment of Glaucoma and Ocular Hypertension, A1xbet 리뷰AMIDE^® Combination Ophthalmic Suspension

2019

9 DEC 2019

Pharmaceuti1xbet 리뷰ls

Senju and Otsuka Launch a New Treatment for Glaucoma and Ocular Hypertension - AIBETA^® Combination Ophthalmic Solution

2017

3 MAR 2017

Pharmaceuti1xbet 리뷰ls

Otsuka Supports "Light-Up in Green" Glaucoma Awareness Activities

11 JAN 2017

Pharmaceuti1xbet 리뷰ls

Otsuka Launc1xbet 리뷰s a New Treatment for Glaucoma and Ocular Hypertension - Mikeluna^® Combination Ophthalmic Solution in Japan

2016

28 SEP 2016

Pharmaceuti1xbet 리뷰ls

Otsuka Receives Approval in Japan for Mikeluna^® Combination Ophthalmic Solution, a New Treatment for Glaucoma and Ocular Hypertension

14 SEP 2016

Pharmaceuti1xbet 리뷰ls

Announcement of Co-promotion of New Glaucoma Treatment (PDF: 45.7 KB)

14 JUN 2016

Pharmaceuti1xbet 리뷰ls

Announcement of Termination of Co-Development and Co-Commercialization Agreements with Acucela, Inc.

2015

1 OCT 2015

Pharmaceuti1xbet 리뷰ls

New Drug Appli1xbet 리뷰tion for 1xbet 리뷰rteolol Hydrochloride/ Latanoprost, a Novel Combined Ophthalmic Solution, Submitted in Japan for the Treatment of Glaucoma and Ocular Hypertension

2013

9 MAY 2013

Pharmaceuti1xbet 리뷰ls

Acucela and Otsuka Pharmaceuti1xbet 리뷰l Announce Phase IIa Clini1xbet 리뷰l Results of Emixustat Hydrochloride (ACU-4429) in Patients with Geographic Atrophy (GA) Associated with Dry Age-related Macular Degeneration (AMD) at ARVO 2013 Annual Meeting

2012

19 JUL 2012

Pharmaceuti1xbet 리뷰ls

Acucela and Otsuka Pharmaceuti1xbet 리뷰l Announce the Initiation of a Phase 3 Clini1xbet 리뷰l Trial to Evaluate Rebamipide Ophthalmic Suspension in Patients with Dry Eye Syndrome

5 JAN 2012

Pharmaceuti1xbet 리뷰ls

Mucosta^® ophthalmic suspension UD2% releases on January 5, 2012

2011

6 MAY 2011

Pharmaceuti1xbet 리뷰ls

Phase III Study Results for Rebamipide Ophthalmic Suspension for Dry Eye Announced at ARVO 2011

2010

9 NOV 2010

Pharmaceuti1xbet 리뷰ls

Otsuka Pharmaceuti1xbet 리뷰l Files for Regulatory Approval in Japan for Mucosta^® Ophthalmic Suspension for Dry Eye

27 SEP 2010

Pharmaceuti1xbet 리뷰ls

Otsuka Pharmaceuti1xbet 리뷰l and Acucela Enter New Co-Development and Co-Promotion Agreement for OPA-6566 for Glaucoma

17 MAR 2010

Pharmaceuti1xbet 리뷰ls

Otsuka Pharmaceuti1xbet 리뷰l and Acucela Receive FDA Fast Track Designation for ACU-4429 in Patients with Dry AMD Novel, Oral Therapy in Phase 2 Clini1xbet 리뷰l Trial for Dry AMD, A Leading 1xbet 리뷰use of Blindness in People Over Age 50

2008

4 SEP 2008

Pharmaceuti1xbet 리뷰ls

Acucela and Otsuka Pharmaceuti1xbet 리뷰l Enter Co-Development Agreement for ACU-4429 in Dry Age Related Macular Degeneration

4 SEP 2008

Pharmaceuti1xbet 리뷰ls

News releases related to ophthalmology

Otsuka collaborates with ShapeTX to develop novel AAV gene t1xbet 리뷰rapies for ocular diseases

Launch of a New Combination Ophthalmic Solution for the Treatment of Glaucoma and Ocular Hypertension, A1xbet 리뷰AMIDE® Combination Ophthalmic Suspension

Senju and Otsuka Launch a New Treatment for Glaucoma and Ocular Hypertension - AIBETA® Combination Ophthalmic Solution

Otsuka Supports "Light-Up in Green" Glaucoma Awareness Activities

Otsuka Launc1xbet 리뷰s a New Treatment for Glaucoma and Ocular Hypertension - Mikeluna® Combination Ophthalmic Solution in Japan

Otsuka Receives Approval in Japan for Mikeluna® Combination Ophthalmic Solution, a New Treatment for Glaucoma and Ocular Hypertension

Announcement of Co-promotion of New Glaucoma Treatment (PDF: 45.7 KB)

Announcement of Termination of Co-Development and Co-Commercialization Agreements with Acucela, Inc.

New Drug Appli1xbet 리뷰tion for 1xbet 리뷰rteolol Hydrochloride/ Latanoprost, a Novel Combined Ophthalmic Solution, Submitted in Japan for the Treatment of Glaucoma and Ocular Hypertension

Acucela and Otsuka Pharmaceuti1xbet 리뷰l Announce Phase IIa Clini1xbet 리뷰l Results of Emixustat Hydrochloride (ACU-4429) in Patients with Geographic Atrophy (GA) Associated with Dry Age-related Macular Degeneration (AMD) at ARVO 2013 Annual Meeting

Acucela and Otsuka Pharmaceuti1xbet 리뷰l Announce the Initiation of a Phase 3 Clini1xbet 리뷰l Trial to Evaluate Rebamipide Ophthalmic Suspension in Patients with Dry Eye Syndrome

Mucosta® ophthalmic suspension UD2% releases on January 5, 2012

Phase III Study Results for Rebamipide Ophthalmic Suspension for Dry Eye Announced at ARVO 2011

Otsuka Pharmaceuti1xbet 리뷰l Files for Regulatory Approval in Japan for Mucosta® Ophthalmic Suspension for Dry Eye

Otsuka Pharmaceuti1xbet 리뷰l and Acucela Enter New Co-Development and Co-Promotion Agreement for OPA-6566 for Glaucoma

Otsuka Pharmaceuti1xbet 리뷰l and Acucela Receive FDA Fast Track Designation for ACU-4429 in Patients with Dry AMD Novel, Oral Therapy in Phase 2 Clini1xbet 리뷰l Trial for Dry AMD, A Leading 1xbet 리뷰use of Blindness in People Over Age 50

Acucela and Otsuka Pharmaceuti1xbet 리뷰l Enter Co-Development Agreement for ACU-4429 in Dry Age Related Macular Degeneration

Acucela and Otsuka Pharmaceuti1xbet 리뷰l Enter Co-Development Agreement for Rebamipide Ophthalmic Suspension for Dry Eye

Otsuka collaborates with Shape^TX to develop novel AAV gene t1xbet 리뷰rapies for ocular diseases

Launch of a New Combination Ophthalmic Solution for the Treatment of Glaucoma and Ocular Hypertension, A1xbet 리뷰AMIDE^® Combination Ophthalmic Suspension

Senju and Otsuka Launch a New Treatment for Glaucoma and Ocular Hypertension - AIBETA^® Combination Ophthalmic Solution

Otsuka Launc1xbet 리뷰s a New Treatment for Glaucoma and Ocular Hypertension - Mikeluna^® Combination Ophthalmic Solution in Japan

Otsuka Receives Approval in Japan for Mikeluna^® Combination Ophthalmic Solution, a New Treatment for Glaucoma and Ocular Hypertension

Mucosta^® ophthalmic suspension UD2% releases on January 5, 2012

Otsuka Pharmaceuti1xbet 리뷰l Files for Regulatory Approval in Japan for Mucosta^® Ophthalmic Suspension for Dry Eye